NCT03809754
Unknown
Not Applicable
Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis: A Prospective Registry Trial
Chinese PLA General Hospital1 site in 1 country240 target enrollmentMarch 1, 2019
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- CHD - Coronary Heart Disease
- Sponsor
- Chinese PLA General Hospital
- Enrollment
- 240
- Locations
- 1
- Primary Endpoint
- In-segment late loss at 9 months follow-up
- Last Updated
- 7 years ago
Overview
Brief Summary
This study is a prospective, registry trial aimed to compare the clinical and angiographic outcomes of OCT-guided and angiography-guided PCI in patients with coronary DES-ISR.
Investigators
Yun Dai Chen
Professor
Chinese PLA General Hospital
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or older
- •Patients with angina or evidence of myocardial ischaemia
- •Patients with restenotic lesions in a previously DES area of a coronary artery
- •Patients suitable to receive any types of percutaneous coronary intervention (including balloon angioplasty and stent implantation)
- •The stent diameter of DES-ISR is 2.5mm to 4.0mm
- •Target lesion length \< 30mm
- •Target lesion stenosis ≥ 70% diameter stenosis on visual assessment, or ≥ 50% diameter stenosis and with evidence of myocardial ischaemia ischemic
Exclusion Criteria
- •Patients with acute myocardial infarction with 1 week
- •Patients with evidence of extensive thrombosis in the target vessel
- •Patients with left main coronary artery disease
- •Patients with cardiogenic shock, left ventricular ejection fraction \< 40%,significant renal dysfunction and severe heart valve disease
- •Patients who had cerebral stroke within 6 months before PCI
- •Patients with a life expectancy \< 1 year
- •Patients not able to adhere to follow-up visits
Outcomes
Primary Outcomes
In-segment late loss at 9 months follow-up
Time Frame: 9 months
Secondary Outcomes
- Rate of 9-month binary restenosis(9 months)
- Rate of myocardial infarction(12 months)
- Rates of acute success(1 month)
- Rate of major adverse cardiovascular events(12 months)
- Number of participants with all-cause death(12 months)
- Number of Participants with target lesion failure (TLF)(12 months)
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).GlaucomaNCT02757677Swiss Vision Network200
Recruiting
Not Applicable
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseDiabetic RetinopathyRetinal Vein OcclusionHypertension,EssentialRetinal Vascular DisorderNCT04505618Johns Hopkins University1,050
Recruiting
Not Applicable
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEntsST Elevation Myocardial InfarctionMyocardial InfarctionNCT06227754Chonnam National University Hospital1,500
Recruiting
Not Applicable
OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent ImplantationOptical Coherence TomographyIntravascular UltrasoundAngiographyNCT03574636Shanghai MicroPort Medical (Group) Co., Ltd.375
Completed
Not Applicable
ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)Coronary Artery DiseaseCoronary StenosisAtherosclerosisSTEMISTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)NCT03507777Abbott Medical Devices2,487